Scabies Treatment Market size is expected to be USD 212.24 million in 2022 to more than USD 322 million by 2028, growing at a high CAGR of 5.1% from 2022 to 2028. Scabies is a contagious skin infection caused by Sarcoptes scabiei. Pimple-like rashes and severe itchiness are the symptoms associated with scabies. The mode of transmission of scabies is skin-to-skin contact. The common site of infestation include armpits, around fingernails, inner elbow, in between fingers, and soles of feet among others. Scabies can be treated with antibiotics, antihistamines, and steroid creams. The Scabies Treatment Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on the global market gives historical, current, and future market sizes (US$ Bn) of drug type (sulfur ointment, benzyl benzoate lotion, lindane lotion, crotamiton cream, permethrin cream, others), route of administration (oral, topical), distribution channel and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes a regulatory scenario and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.